PUMA BIOTECHNOLOGY, INC. (PBYI) Gross margin 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.5%FY2025 · since FY2017: 79.9% → 74.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.5% | +2.5 pp |
| FY2024 | 72.1% | -1.3 pp |
| FY2023 | 73.4% | -2.4 pp |
| FY2022 | 75.8% | +1.0 pp |
| FY2021 | 74.8% | -7.7 pp |
| FY2020 | 82.5% | -4.0 pp |
| FY2019 | 86.5% | +0.3 pp |
| FY2018 | 86.2% | +6.3 pp |
| FY2017 | 79.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice